← FDA DRUG APPROVALS

FDA ANDA · ANDA202648

GRANISETRON HYDROCHLORIDE

Sponsor: YUNG SHIN PHARM

APPLICATION
ANDA202648
TYPE
ANDA
ORIGINAL APPROVAL
2020-06-29
LATEST ACTION
2020-06-29
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

GRANISETRON HYDROCHLORIDEDiscontinued
GRANISETRON HYDROCHLORIDE EQ 4MG BASE/4ML (EQ 1MG BASE/ML) · INJECTABLE · INJECTION
GRANISETRON HYDROCHLORIDEDiscontinued
GRANISETRON HYDROCHLORIDE EQ 1MG BASE/ML (EQ 1MG BASE/ML) · INJECTABLE · INJECTION

Approval history

2020-06-29UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →